Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
First Trust Global Tactical Commodity Strategy Fund
FTGC
$3.09B
| $1.51M | ﹤0.01% |
67,403
+14,003
| +26% | +$326K |
|
2127
SoundThinking
SSTI
$81.6M
| $1.51M | ﹤0.01% |
59,232
-3,300
| -5% | -$67.3K |
|
|
TDCX
2128
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
| $1.51M | ﹤0.01% |
311,588
-2,612
| -0.8% | -$12.8K |
|
2129
Altisource Portfolio Solutions
ASPS
$64.4M
| $1.51M | ﹤0.01% |
52,978
+13
| +0% | +$412 |
|
2130
RF Industries
RFIL
$148M
| $1.51M | ﹤0.01% |
495,608
-10,200
| -2% | -$28.5K |
|
|
CTLP
2131
DELISTED
Cantaloupe
CTLP
| $1.51M | ﹤0.01% |
203,200
+77,400
| +62% | +$535K |
|
2132
Journey Medical
DERM
$190M
| $1.5M | ﹤0.01% |
261,000
+240,100
| +1,149% | +$1.07M |
|
|
CMRX
2133
DELISTED
Chimerix, Inc.
CMRX
| $1.5M | ﹤0.01% |
1,562,009
+520,900
| +50% | +$504K |
|
2134
Xenon Pharmaceuticals
XENE
$6.03B
| $1.5M | ﹤0.01% |
32,600
+10,700
| +49% | +$378K |
|
2135
Latham Group
SWIM
$861M
| $1.5M | ﹤0.01% |
570,800
-9,217
| -2% | -$22.8K |
|
2136
CarGurus
CARG
$3.33B
| $1.5M | ﹤0.01% |
62,000
-550,200
| -90% | -$11.1M |
|
2137
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.76B
| $1.5M | ﹤0.01% |
+30,000
| New | +$1.4M |
|
2138
Telephone and Data Systems
TDS
$4.05B
| $1.5M | ﹤0.01% |
81,584
-82,501
| -50% | -$1.52M |
|
2139
Seer Inc
SEER
$115M
| $1.49M | ﹤0.01% |
768,600
+442,500
| +136% | +$787K |
|
2140
DXP Enterprises
DXPE
$3.12B
| $1.49M | ﹤0.01% |
44,200
-38,500
| -47% | -$1.26M |
|
2141
HUTCHMED
HCM
$2.12B
| $1.49M | ﹤0.01% |
82,300
+30,300
| +58% | +$551K |
|
2142
Granite Ridge Resources
GRNT
$674M
| $1.49M | ﹤0.01% |
247,100
+72,604
| +42% | +$443K |
|
2143
Citizens & Northern Corp
CZNC
$466M
| $1.49M | ﹤0.01% |
66,241
-2,300
| -3% | -$45.4K |
|
2144
Peoples Financial Services
PFIS
$714M
| $1.48M | ﹤0.01% |
30,444
+4,463
| +17% | +$191K |
|
2145
Procore
PCOR
$9.09B
| $1.48M | ﹤0.01% |
21,400
-87,900
| -80% | -$5.42M |
|
2146
Ecopetrol
EC
$35.3B
| $1.48M | ﹤0.01% |
124,135
-81,700
| -40% | -$991K |
|
|
CNTA
2147
DELISTED
Centessa Pharmaceuticals
CNTA
| $1.48M | ﹤0.01% |
185,600
+132,500
| +250% | +$888K |
|
2148
Allot
ALLT
$383M
| $1.48M | ﹤0.01% |
894,606
-14,700
| -2% | -$24.5K |
|
2149
iShares MSCI Italy ETF
EWI
$1.08B
| $1.48M | ﹤0.01% |
+43,500
| New | +$1.38M |
|
2150
Twin Disc
TWIN
$354M
| $1.48M | ﹤0.01% |
91,293
+3,100
| +4% | +$43.8K |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.